Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Myasthenia Gravis Treatment Market, by End-use
1.4.2 LAMEA Myasthenia Gravis Treatment Market, by Type
1.4.3 LAMEA Myasthenia Gravis Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. LAMEA Myasthenia Gravis Treatment Market by End-use
4.1 LAMEA Hospitals Market by Country
4.2 LAMEA Clinics Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Myasthenia Gravis Treatment Market by Type
5.1 LAMEA Monoclonal Antibodies Market by Country
5.2 LAMEA Thymectomy Market by Country
5.3 LAMEA Cholinesterase Inhibitors Market by Country
5.4 LAMEA Chronic Immunomodulators Market by Country
5.5 LAMEA Rapid Immunotherapies Market by Country
5.6 LAMEA Others Market by Country
Chapter 6. LAMEA Myasthenia Gravis Treatment Market by Country
6.1 Brazil Myasthenia Gravis Treatment Market
6.1.1 Brazil Myasthenia Gravis Treatment Market by End-use
6.1.2 Brazil Myasthenia Gravis Treatment Market by Type
6.2 Argentina Myasthenia Gravis Treatment Market
6.2.1 Argentina Myasthenia Gravis Treatment Market by End-use
6.2.2 Argentina Myasthenia Gravis Treatment Market by Type
6.3 UAE Myasthenia Gravis Treatment Market
6.3.1 UAE Myasthenia Gravis Treatment Market by End-use
6.3.2 UAE Myasthenia Gravis Treatment Market by Type
6.4 Saudi Arabia Myasthenia Gravis Treatment Market
6.4.1 Saudi Arabia Myasthenia Gravis Treatment Market by End-use
6.4.2 Saudi Arabia Myasthenia Gravis Treatment Market by Type
6.5 South Africa Myasthenia Gravis Treatment Market
6.5.1 South Africa Myasthenia Gravis Treatment Market by End-use
6.5.2 South Africa Myasthenia Gravis Treatment Market by Type
6.6 Nigeria Myasthenia Gravis Treatment Market
6.6.1 Nigeria Myasthenia Gravis Treatment Market by End-use
6.6.2 Nigeria Myasthenia Gravis Treatment Market by Type
6.7 Rest of LAMEA Myasthenia Gravis Treatment Market
6.7.1 Rest of LAMEA Myasthenia Gravis Treatment Market by End-use
6.7.2 Rest of LAMEA Myasthenia Gravis Treatment Market by Type
Chapter 7. Company Profiles
7.1 AstraZeneca PLC (Alexion Pharmaceuticals, Inc.)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Approval and Trails:
7.1.6 SWOT Analysis
7.2 Octapharma AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Research & Development Expenses
7.3 Novartis AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional & Segmental Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approval and Trails:
7.4.6 SWOT Analysis
7.5 Allergan PLC (AbbVie, Inc.)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.1 Research & Development Expense
7.5.2 SWOT Analysis
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 GlaxoSmithKline PLC (GSK)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 Bausch Health Companies Inc
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 SWOT Analysis
7.9 Kedrion S.p.A
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Research & Development Expenses
7.9.4 SWOT Analysis
7.10. Zydus Lifesciences Ltd.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis



List of Figures

FIG 1 Methodology for the research
FIG 2 LAMEA Myasthenia Gravis Treatment Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Myasthenia Gravis Treatment Market
FIG 4 Porter’s Five Forces Analysis – Myasthenia Gravis Treatment Market
FIG 5 LAMEA Myasthenia Gravis Treatment Market share by End-use, 2022
FIG 6 LAMEA Myasthenia Gravis Treatment Market share by End-use, 2030
FIG 7 LAMEA Myasthenia Gravis Treatment Market by End-use, 2019 - 2030, USD Million
FIG 8 LAMEA Myasthenia Gravis Treatment Market share by Type, 2022
FIG 9 LAMEA Myasthenia Gravis Treatment Market share by Type, 2030
FIG 10 LAMEA Myasthenia Gravis Treatment Market by Type, 2019 - 2030, USD Million
FIG 11 LAMEA Myasthenia Gravis Treatment Market share by Country, 2022
FIG 12 LAMEA Myasthenia Gravis Treatment Market share by Country, 2030
FIG 13 LAMEA Myasthenia Gravis Treatment Market by Country, 2019 - 2030, USD Million
FIG 14 SWOT Analysis: AstraZeneca PLC
FIG 15 SWOT Analysis: Novartis AG
FIG 16 SWOT Analysis: Pfizer, Inc.
FIG 17 SWOT Analysis: Allergan PLC
FIG 18 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 19 SWOT Analysis: GlaxoSmithKline PLC
FIG 20 SWOT Analysis: Bausch Health Companies Inc
FIG 21 SWOT Analysis: Kedrion S.p.A
FIG 22 SWOT Analysis: Zydus Lifesciences Ltd.

List of Tables

TABLE 1 LAMEA Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 3 LAMEA Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 4 LAMEA Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 5 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Clinics Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Clinics Market by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 12 LAMEA Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 13 LAMEA Monoclonal Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Monoclonal Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Thymectomy Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Thymectomy Market by Country, 2023 - 2030, USD Million
TABLE 17 LAMEA Cholinesterase Inhibitors?Market by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Cholinesterase Inhibitors?Market by Country, 2023 - 2030, USD Million
TABLE 19 LAMEA Chronic Immunomodulators?Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Chronic Immunomodulators?Market by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Rapid Immunotherapies?Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Rapid Immunotherapies?Market by Country, 2023 - 2030, USD Million
TABLE 23 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Myasthenia Gravis Treatment Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Myasthenia Gravis Treatment Market by Country, 2023 - 2030, USD Million
TABLE 27 Brazil Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 28 Brazil Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 29 Brazil Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 30 Brazil Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 31 Brazil Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 32 Brazil Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 33 Argentina Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 34 Argentina Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 35 Argentina Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 36 Argentina Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 37 Argentina Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 38 Argentina Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 39 UAE Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 40 UAE Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 41 UAE Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 42 UAE Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 43 UAE Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 44 UAE Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 45 Saudi Arabia Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 46 Saudi Arabia Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 47 Saudi Arabia Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 48 Saudi Arabia Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 49 Saudi Arabia Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 50 Saudi Arabia Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 51 South Africa Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 52 South Africa Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 53 South Africa Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 54 South Africa Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 55 South Africa Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 56 South Africa Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 57 Nigeria Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 58 Nigeria Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 59 Nigeria Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 60 Nigeria Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 61 Nigeria Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 62 Nigeria Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 63 Rest of LAMEA Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 64 Rest of LAMEA Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 65 Rest of LAMEA Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 66 Rest of LAMEA Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 67 Rest of LAMEA Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 68 Rest of LAMEA Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 69 KEY INFORMATION – ASTRAZENECA PLC
TABLE 70 Key Information – Octapharma AG
TABLE 71 Key Information – Novartis AG
TABLE 72 Key Information – Pfizer, Inc.
TABLE 73 Key Information – Allergan PLC
TABLE 74 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 75 Key Information – GlaxoSmithKline PLC
TABLE 76 Key Information – Bausch Health Companies Inc
TABLE 77 key Information – Kedrion S.p.A
TABLE 78 Key Information – Zydus Lifesciences Ltd.